只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-28 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Capital Advisors LLC Director,TenPercentOwner,Other | 买入（P） | 7,905 | US$18.25 | US$144,266.25 | 3,088,888 | SEC |
| 2026-07-28 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Ventures LLC Director,Other | 买入（P） | 7,905 | US$18.25 | US$144,266.25 | 3,088,888 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | OrbiMed Capital GP VIII LLC Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L Director | 买入（P） | 1,000,000 | US$15.00 | US$1500万 | 1,348,825 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Equity Partners Bio II, L.L.C. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund III, L.P. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | AH Equity Partners Bio III, L.L.C. TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | Andreessen Marc L TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-27 2026-07-29 | SCTX Scribe Therapeutics, Inc. | HOROWITZ BENJAMIN A TenPercentOwner | 买入（P） | 333,333 | US$15.00 | US$500万 | 2,385,075 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad Director,TenPercentOwner,Other | 买入（P） | 2,333,333 | US$15.00 | US$3500万 | 3,030,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Capital Advisors LLC Director,TenPercentOwner,Other | 买入（P） | 2,333,333 | US$15.00 | US$3500万 | 3,030,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Ventures LLC Director,Other | 买入（P） | 2,333,333 | US$15.00 | US$3500万 | 3,030,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad Director,TenPercentOwner,Other | 买入（P） | 50,000 | US$22.31 | US$111.55万 | 3,080,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Capital Advisors LLC Director,TenPercentOwner,Other | 买入（P） | 50,000 | US$22.31 | US$111.55万 | 3,080,983 | SEC |
| 2026-07-24 2026-07-28 | SCTX Scribe Therapeutics, Inc. | Avoro Ventures LLC Director,Other | 买入（P） | 50,000 | US$22.31 | US$111.55万 | 3,080,983 | SEC |
| 2026-07-23 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Lucas Svetlana Officer · Chief Business Officer | 买入（P） | 3,000 | US$15.00 | US$45,000.00 | 3,000 | SEC |
| 2026-07-23 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Parrot David Officer · Chief Financial Officer | 买入（P） | 1,333 | US$15.00 | US$19,995.00 | 1,333 | SEC |
| 2026-07-23 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Parrot David Officer · Chief Financial Officer | 买入（P） | 1,333 | US$15.00 | US$19,995.00 | 1,333 | SEC |
| 2026-07-21 2026-07-23 | ACRV Acrivon Therapeutics, Inc. | Miller Mary Officer · Chief Legal Officer | 卖出（S） | 573 | US$1.76 | US$1,008.48 | 82,194 | SEC |
| 2026-07-17 2026-07-17 | CRCT Cricut, Inc. | Ashish Arora Director,Officer,TenPercentOwner · Chief Executive Officer | 卖出（S） | 2,282 | US$4.75 | US$10,845.21 | 4,321,893 | SEC |
| 2026-07-15 2026-07-17 | CRCT Cricut, Inc. | Ashish Arora Director,Officer,TenPercentOwner · Chief Executive Officer | 卖出（S） | 1,051 | US$4.75 | US$4,996.87 | 4,324,175 | SEC |
| 2026-07-10 2026-07-13 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 4,367 | US$181.02 | US$790,514.34 | 16,225 | SEC |
| 2026-07-09 2026-07-13 | NBIX NEUROCRINE BIOSCIENCES INC | Lippoldt Darin Officer · Chief Legal Officer | 卖出（S） | 10,000 | US$179.60 | US$179.6万 | 54,729 | SEC |
| 2026-07-09 2026-07-09 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 8,433 | US$178.72 | US$150.71万 | 16,225 | SEC |
| 2026-07-08 2026-07-09 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 2,737 | US$178.54 | US$488,672.19 | 16,225 | SEC |
| 2026-07-07 2026-07-09 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 3,401 | US$178.57 | US$607,305.01 | 16,225 | SEC |
| 2026-07-02 2026-07-07 | CRNX Crinetics Pharmaceuticals, Inc. | Vivaldi Coelho Rogerio Director | 卖出（S） | 3,000 | US$40.00 | US$120,000.00 | 19,225 | SEC |
| 2026-06-29 2026-06-30 | NBIX NEUROCRINE BIOSCIENCES INC | Lippoldt Darin Officer · Chief Legal Officer | 卖出（S） | 1,690 | US$170.81 | US$288,668.90 | 54,729 | SEC |
| 2026-06-29 2026-06-30 | NBIX NEUROCRINE BIOSCIENCES INC | Lippoldt Darin Officer · Chief Legal Officer | 卖出（S） | 8,110 | US$170.03 | US$137.89万 | 54,729 | SEC |
| 2026-06-26 2026-06-30 | NBIX NEUROCRINE BIOSCIENCES INC | Lippoldt Darin Officer · Chief Legal Officer | 卖出（S） | 200 | US$169.57 | US$33,914.00 | 54,729 | SEC |
| 2026-06-17 2026-06-18 | CRNX Crinetics Pharmaceuticals, Inc. | Okey Stephanie Director | 卖出（S） | 608 | US$36.22 | US$22,021.76 | 6,400 | SEC |
| 2026-06-17 2026-06-18 | CRNX Crinetics Pharmaceuticals, Inc. | Okey Stephanie Director | 卖出（S） | 6,292 | US$35.62 | US$224,121.04 | 7,008 | SEC |
| 2026-06-12 2026-06-16 | CXT Crane NXT, Co. | Cristiano Christina Officer · SVP, Chief Financial Officer | 买入（P） | 3,550 | US$41.96 | US$148,958.00 | 14,663 | SEC |
| 2026-06-08 2026-06-10 | SRTA Strata Critical Medical, Inc. | Wunsch Scott M Officer · CEO, Logistics | 卖出（S） | 5,550 | US$5.87 | US$32,578.50 | 625,574 | SEC |
| 2026-06-08 2026-06-10 | SRTA Strata Critical Medical, Inc. | Tomkiel Melissa M. Director,Officer · Co-CEO and General Counsel | 卖出（S） | 29,730 | US$5.87 | US$174,515.10 | 1,892,774 | SEC |
| 2026-06-08 2026-06-10 | SRTA Strata Critical Medical, Inc. | Cohen Amir Officer · Chief Accounting Officer | 卖出（S） | 4,655 | US$5.87 | US$27,324.85 | 146,608 | SEC |
| 2026-06-08 2026-06-10 | SRTA Strata Critical Medical, Inc. | Heyburn William A. Director,Officer · Co-CEO and CFO | 卖出（S） | 31,671 | US$5.87 | US$185,908.77 | 1,548,997 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 7,883 | US$163.81 | US$129.13万 | 32,977 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 2,549 | US$164.44 | US$419,157.56 | 30,428 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 6,896 | US$165.79 | US$114.33万 | 23,532 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 5,829 | US$166.56 | US$970,878.24 | 17,703 | SEC |
| 2026-06-05 2026-06-09 | NBIX NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A Director | 卖出（S） | 1,843 | US$167.31 | US$308,352.33 | 15,860 | SEC |
| 2026-06-05 2026-06-08 | VICR VICOR CORP | CRILLY SEAN Officer · Corp. VP-Eng., Pwr Syst. | 卖出（S） | 2,500 | US$282.52 | US$706,300.00 | 7,229 | SEC |
| 2026-06-04 2026-06-08 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V Director | 卖出（S） | 1,250 | US$168.06 | US$210,075.00 | 2,838 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 3,520 | US$158.59 | US$558,236.80 | 22,374 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 9,521 | US$157.62 | US$150.07万 | 25,894 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 4,216 | US$156.77 | US$660,942.32 | 35,415 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 5,466 | US$155.46 | US$849,744.36 | 39,631 | SEC |
| 2026-06-02 2026-06-04 | NBIX NEUROCRINE BIOSCIENCES INC | Cooke Julie Officer · Chief Human Resources Officer | 卖出（S） | 14,214 | US$154.83 | US$220.08万 | 45,097 | SEC |
| 2026-06-02 2026-06-03 | ROKU ROKU, INC | Fuchsberg Gilbert Officer · President, Subscriptions | 卖出（S） | 4,376 | US$127.26 | US$556,889.76 | 51,099 | SEC |
| 2026-06-01 2026-06-03 | CRCT Cricut, Inc. | Ashish Arora Director,Officer,TenPercentOwner · Chief Executive Officer | 卖出（S） | 16,366 | US$4.30 | US$70,373.80 | 4,325,226 | SEC |
| 2026-06-01 2026-06-02 | CRTO Criteo S.A. | Glickman Sarah JS Officer · Chief Financial Officer | 卖出（S） | 982 | US$18.50 | US$18,167.00 | 430,897 | SEC |
| 2026-06-01 2026-06-02 | CRTO Criteo S.A. | Damon Ryan Officer · Chief Legal Officer | 卖出（S） | 1,079 | US$18.50 | US$19,961.50 | 173,943 | SEC |
| 2026-06-01 2026-06-02 | NBIX NEUROCRINE BIOSCIENCES INC | Onyia Jude Officer · Chief Scientific Officer | 卖出（S） | 11,000 | US$160.25 | US$176.28万 | 25,846 | SEC |
| 2026-05-29 2026-06-02 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid Officer · Chief Regulatory Officer | 卖出（S） | 2,261 | US$156.71 | US$354,321.31 | 16,225 | SEC |
| 2026-05-29 2026-06-01 | CRSP CRISPR Therapeutics AG | Patel Naimish Officer · Chief Medical Officer | 卖出（S） | 3,786 | US$55.62 | US$210,577.32 | 19,357 | SEC |
| 2026-05-28 2026-06-01 | CRCT Cricut, Inc. | Harmer Ryan Officer · Principal Accounting Officer | 卖出（S） | 17,267 | US$4.12 | US$71,140.04 | 325,579 | SEC |
| 2026-05-28 2026-05-29 | MCRI MONARCH CASINO & RESORT INC | FARAHI JOHN Director,Officer,TenPercentOwner · CEO | 卖出（S） | 5,000 | US$120.84 | US$604,200.00 | 616,556 | SEC |
| 2026-05-28 2026-05-28 | EOG EOG RESOURCES INC | CRISP CHARLES R Director | 卖出（S） | 1,887 | US$136.17 | US$256,952.79 | 63,160.26 | SEC |
| 2026-05-27 2026-05-29 | NBIX NEUROCRINE BIOSCIENCES INC | Onyia Jude Officer · Chief Scientific Officer | 卖出（S） | 11,000 | US$155.53 | US$171.08万 | 25,846 | SEC |
| 2026-05-26 2026-05-28 | CRTO Criteo S.A. | Glickman Sarah JS Officer · Chief Financial Officer | 卖出（S） | 1,313 | US$17.06 | US$22,399.78 | 433,031 | SEC |
| 2026-05-26 2026-05-28 | CRTO Criteo S.A. | Glickman Sarah JS Officer · Chief Financial Officer | 卖出（S） | 1,152 | US$17.06 | US$19,653.12 | 431,879 | SEC |
| 2026-05-26 2026-05-28 | CRTO Criteo S.A. | Damon Ryan Officer · Chief Legal Officer | 卖出（S） | 996 | US$17.06 | US$16,991.76 | 175,022 | SEC |
| 2026-05-26 2026-05-28 | CRTO Criteo S.A. | Damon Ryan Officer · Chief Legal Officer | 卖出（S） | 1,136 | US$17.06 | US$19,380.16 | 176,018 | SEC |
| 2026-05-26 2026-05-28 | NBIX NEUROCRINE BIOSCIENCES INC | Boyer David W. Officer · Chief Corp. Affairs Officer | 卖出（S） | 3,888 | US$156.64 | US$609,016.32 | 7,799 | SEC |
| 2026-05-22 2026-05-26 | SRTA Strata Critical Medical, Inc. | Cohen Amir Officer · Chief Accounting Officer | 卖出（S） | 40,575 | US$5.91 | US$239,798.25 | 151,263 | SEC |
| 2026-05-22 2026-05-26 | CWGL Crimson Wine Group, Ltd | STEINBERG JOSEPH S Director,TenPercentOwner | 买入（P） | 7,474 | US$4.05 | US$30,269.70 | 1,272,011 | SEC |
| 2026-05-22 2026-05-26 | CRCT Cricut, Inc. | Ashish Arora Director,Officer,TenPercentOwner · Chief Executive Officer | 卖出（S） | 60,000 | US$3.98 | US$238,800.00 | 4,341,592 | SEC |
| 2026-05-21 2026-05-26 | SRTA Strata Critical Medical, Inc. | Cohen Amir Officer · Chief Accounting Officer | 卖出（S） | 10,300 | US$5.79 | US$59,637.00 | 191,838 | SEC |
| 2026-05-21 2026-05-22 | CWGL Crimson Wine Group, Ltd | Quille Nicolas Michel Eric Officer · Chief Winemaking & COO | 买入（P） | 1,000 | US$4.03 | US$4,030.00 | 3,500 | SEC |
| 2026-05-21 2026-05-21 | CRCT Cricut, Inc. | Ashish Arora Director,Officer,TenPercentOwner · Chief Executive Officer | 卖出（S） | 60,000 | US$3.95 | US$237,000.00 | 4,401,592 | SEC |
| 2026-05-20 2026-05-22 | SSP E.W. SCRIPPS Co | McCabe Molly E TenPercentOwner | 卖出（S） | 11,239 | US$3.29 | US$36,976.31 | 0 | SEC |
| 2026-05-20 2026-05-21 | CRCT Cricut, Inc. | Ashish Arora Director,Officer,TenPercentOwner · Chief Executive Officer | 卖出（S） | 60,000 | US$3.95 | US$237,000.00 | 4,461,592 | SEC |
| 2026-05-19 2026-05-22 | SSP E.W. SCRIPPS Co | McCabe Molly E TenPercentOwner | 卖出（S） | 112,284 | US$3.40 | US$381,765.60 | 11,239 | SEC |
| 2026-05-19 2026-05-21 | NBIX NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES Director | 卖出（S） | 245,088 | US$154.33 | US$3782.44万 | 511,293 | SEC |
| 2026-05-18 2026-05-22 | SSP E.W. SCRIPPS Co | McCabe Molly E TenPercentOwner | 卖出（S） | 142,970 | US$3.48 | US$497,535.60 | 123,523 | SEC |
| 2026-05-15 2026-05-22 | SSP E.W. SCRIPPS Co | McCabe Molly E TenPercentOwner | 卖出（S） | 60,182 | US$3.35 | US$201,609.70 | 266,493 | SEC |
| 2026-05-15 2026-05-18 | NBIX NEUROCRINE BIOSCIENCES INC | POPS RICHARD F Director | 卖出（S） | 15,000 | US$157.65 | US$236.48万 | 34,480 | SEC |
| 2026-05-14 2026-05-15 | SSP E.W. SCRIPPS Co | Granado Geraldine Scripps TenPercentOwner | 买入（P） | 72,798 | US$3.54 | US$257,704.92 | 144,902 | SEC |
| 2026-05-13 2026-05-14 | SSP E.W. SCRIPPS Co | Brickner Samantha J. TenPercentOwner | 买入（P） | 1,262 | US$3.53 | US$4,454.86 | 111,695 | SEC |
| 2026-05-13 2026-05-13 | CRCT Cricut, Inc. | Makler Jason Director | 买入（P） | 310 | US$4.15 | US$1,286.50 | 30,000 | SEC |
| 2026-05-12 2026-05-14 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V Director | 卖出（S） | 3,810 | US$155.01 | US$590,588.10 | 2,429 | SEC |
| 2026-05-12 2026-05-13 | TRGP Targa Resources Corp. | CRISP CHARLES R Director | 卖出（S） | 10,602 | US$255.96 | US$271.37万 | 66,492 | SEC |
| 2026-05-12 2026-05-13 | CRCT Cricut, Inc. | Makler Jason Director | 买入（P） | 9,691 | US$4.34 | US$42,058.94 | 29,690 | SEC |
| 2026-05-11 2026-05-13 | SRTA Strata Critical Medical, Inc. | Cohen Amir Officer · Chief Accounting Officer | 卖出（S） | 14,306 | US$5.79 | US$82,831.74 | 202,138 | SEC |
| 2026-05-06 2026-05-06 | VIAV VIAVI SOLUTIONS INC. | SCRIVANICH LUKE M Officer · SVP General Manager OSP | 卖出（S） | 7,258 | US$53.00 | US$384,674.00 | 42,722 | SEC |
| 2026-05-06 2026-05-06 | VIAV VIAVI SOLUTIONS INC. | SCRIVANICH LUKE M Officer · SVP General Manager OSP | 卖出（S） | 3,435 | US$53.00 | US$182,055.00 | 39,287 | SEC |
| 2026-05-06 2026-05-06 | KMB KIMBERLY CLARK CORP | Scribner Andrew Officer · Controller, VP & FP&A | 卖出（S） | 4,095 | US$98.00 | US$401,310.00 | 0 | SEC |
| 2026-05-05 2026-05-06 | QCOM QUALCOMM INC/DE | AMON CRISTIANO R Director,Officer · President & CEO | 卖出（S） | 10,000 | US$185.00 | US$185万 | 197,568 | SEC |
| 2026-05-04 2026-05-04 | QCOM QUALCOMM INC/DE | AMON CRISTIANO R Director,Officer · President & CEO | 卖出（S） | 10,000 | US$180.00 | US$180万 | 207,568 | SEC |
| 2026-05-01 2026-05-05 | ROKU ROKU, INC | Fuchsberg Gilbert Officer · President, Subscriptions | 卖出（S） | 9,593 | US$125.52 | US$120.41万 | 50,863 | SEC |
| 2026-05-01 2026-05-04 | BPOP POPULAR, INC. | GONZALEZ-NOGUERA MARIA CRISTINA Officer · Executive Vice President | 卖出（S） | 6,200 | US$148.51 | US$920,762.00 | 11,255.26 | SEC |
| 2026-04-14 2026-04-15 | FBYD Falcon's Beyond Global, Inc. | Erudite Cria, Inc. TenPercentOwner | 卖出（S） | 3,950,000 | US$0.00 | US$0.00 | 17,413,249 | SEC |
| 2026-04-14 2026-04-14 | PLAB PHOTRONICS INC | MACRICOSTAS CONSTANTINE S Director | 卖出（S） | 50,000 | US$45.35 | US$226.75万 | 0 | SEC |
| 2026-04-08 2026-04-10 | PLAB PHOTRONICS INC | MACRICOSTAS GEORGE Officer · CEO | 卖出（S） | 5,500 | US$43.28 | US$238,040.00 | 443,262 | SEC |
| 2026-04-08 2026-04-10 | PLAB PHOTRONICS INC | MACRICOSTAS GEORGE Officer · CEO | 卖出（S） | 109,194 | US$42.90 | US$468.44万 | 334,068 | SEC |
| 2026-04-08 2026-04-10 | PLAB PHOTRONICS INC | MACRICOSTAS GEORGE Officer · CEO | 卖出（S） | 6,500 | US$43.27 | US$281,255.00 | 448,762 | SEC |
| 2026-04-08 2026-04-10 | CRNX Crinetics Pharmaceuticals, Inc. | Knight Jeff E. Officer · Chief Dev. & Operating Officer | 卖出（S） | 85,163 | US$40.10 | US$341.5万 | 105,289 | SEC |
| 2026-03-31 2026-04-01 | CRIS CURIS INC | KAITIN KENNETH I Director | 买入（P） | 10,000 | US$0.55 | US$5,500.00 | 11,407 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| CRIS | 4,223.8684 | 0 | 8,663.9777 | 48.75% | Q, N |
| CRI | 412,750.4995 | 776 | 878,712.7499 | 46.97% | B, Q, N |
| MCRI | 23,186.7793 | 80 | 54,837.8886 | 42.28% | B, Q, N |